48
Participants
Start Date
July 10, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
July 31, 2027
10 ug HDT 321
HDT-321 Investigational Vaccine (a Nanoparticle Carrier-Formulated self-amplifying RNA encoding the NP of CCHFV)
25ug HDT-321
HDT-321 Investigational Vaccine (a Nanoparticle Carrier-Formulated self-amplifying RNA encoding the NP of CCHFV)
50ug HDT-321
HDT-321 Investigational Vaccine (a Nanoparticle Carrier-Formulated self-amplifying RNA encoding the NP of CCHFV)
RECRUITING
Flourish Research San Antonio (Clinical Trials of Texas), San Antonio
Lead Sponsor
Collaborators (2)
DFNet Research Inc.
OTHER
Technical Resources International, Inc. (TRI)
UNKNOWN
BioAgilytix Labs, LLC
UNKNOWN
The University of Texas Medical Branch, Galveston
OTHER
Clinical Trials of Texas, Inc.
OTHER
Quest Laboratories
UNKNOWN
HDT Bio
INDUSTRY